The fight against illegal distribution of medicines and other pharmaceuticals is now being directed to courier services.
The intensified action follows a recent nationwide audit of health facilities aimed at identifying and addressing malpractices within the pharmaceutical sector.
Kaluai said the data gathered during the surveillance would help pinpoint patterns in illegal pharmaceutical activities, enabling intelligence-based enforcement to better target these issues.
He has called for collaboration between PPB and other government agencies at border points to prevent the entry of unregistered pharmaceuticals, further strengthening safeguards for public health.
“The PPB is urging the public to remain vigilant and report any suspected illegal activities within the sector.”
Kaluai has reiterated the board’s commitment to reducing health risks associated with medication errors due to non-compliant distribution and transportation practices.
In July, PPB acquired the advanced Near Infrared (NIR) technology, the Pillscan, to strengthen its efforts in safeguarding drug quality in the country.
Provided by the Mission of Essential Medicines and Supplies, the new tool is being used for on-site screening of medical products at PPB regional offices and key entry points.
“By incorporating NIR technology into its operations, the PPB aims to bolster its surveillance of the Kenyan pharmaceutical market and protect public health.”
Currently, PPB randomly collects samples from all over the country and analyses them at the National Quality Control Laboratory to test for quality, safety and efficacy.
